These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27179759)

  • 1. Transfer of malignant trait to BRCA1 deficient human fibroblasts following exposure to serum of cancer patients.
    Hamam D; Abdouh M; Gao ZH; Arena V; Arena M; Arena GO
    J Exp Clin Cancer Res; 2016 May; 35():80. PubMed ID: 27179759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes isolated from cancer patients' sera transfer malignant traits and confer the same phenotype of primary tumors to oncosuppressor-mutated cells.
    Abdouh M; Hamam D; Gao ZH; Arena V; Arena M; Arena GO
    J Exp Clin Cancer Res; 2017 Aug; 36(1):113. PubMed ID: 28854931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfer of malignant trait to immortalized human cells following exposure to human cancer serum.
    Abdouh M; Zhou S; Arena V; Arena M; Lazaris A; Onerheim R; Metrakos P; Arena GO
    J Exp Clin Cancer Res; 2014 Sep; 33(1):86. PubMed ID: 25266310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer-derived extracellular vesicles induce transformation of fibroblasts into colon carcinoma cells.
    Abdouh M; Floris M; Gao ZH; Arena V; Arena M; Arena GO
    J Exp Clin Cancer Res; 2019 Jun; 38(1):257. PubMed ID: 31200749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAF-like state in primary skin fibroblasts with constitutional BRCA1 epimutation sheds new light on tumor suppressor deficiency-related changes in healthy tissue.
    Etzold A; Galetzka D; Weis E; Bartsch O; Haaf T; Spix C; Itzel T; Schweiger S; Strand D; Strand S; Zechner U
    Epigenetics; 2016; 11(2):120-31. PubMed ID: 26949839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9-Mediated BRCA1 Knockdown Adipose Stem Cells Promote Breast Cancer Progression.
    Zhao R; Kaakati R; Liu X; Xu L; Lee AK; Bachelder R; Li CY; Hollenbeck ST
    Plast Reconstr Surg; 2019 Mar; 143(3):747-756. PubMed ID: 30817646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth retardation, DNA repair defects, and lack of spermatogenesis in BRCA1-deficient mice.
    Cressman VL; Backlund DC; Avrutskaya AV; Leadon SA; Godfrey V; Koller BH
    Mol Cell Biol; 1999 Oct; 19(10):7061-75. PubMed ID: 10490643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming Malignant Cancer Cells toward a Benign Phenotype following Exposure to Human Embryonic Stem Cell Microenvironment.
    Zhou S; Abdouh M; Arena V; Arena M; Arena GO
    PLoS One; 2017; 12(1):e0169899. PubMed ID: 28068409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mouse model for the molecular characterization of brca1-associated ovarian carcinoma.
    Xing D; Orsulic S
    Cancer Res; 2006 Sep; 66(18):8949-53. PubMed ID: 16982732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor prone phenotype of mice deficient in a novel apoptosis-inducing gene, drs.
    Tambe Y; Yoshioka-Yamashita A; Mukaisho K; Haraguchi S; Chano T; Isono T; Kawai T; Suzuki Y; Kushima R; Hattori T; Goto M; Yamada S; Kiso M; Saga Y; Inoue H
    Carcinogenesis; 2007 Apr; 28(4):777-84. PubMed ID: 17088259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Mouse Model That Reproduces the Developmental Pathways and Site Specificity of the Cancers Associated With the Human BRCA1 Mutation Carrier State.
    Liu Y; Yen HY; Austria T; Pettersson J; Peti-Peterdi J; Maxson R; Widschwendter M; Dubeau L
    EBioMedicine; 2015 Oct; 2(10):1318-30. PubMed ID: 26629527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atm heterozygosity cooperates with loss of Brca1 to increase the severity of mammary gland cancer and reduce ductal branching.
    Bowen TJ; Yakushiji H; Montagna C; Jain S; Ried T; Wynshaw-Boris A
    Cancer Res; 2005 Oct; 65(19):8736-46. PubMed ID: 16204043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer cell response to genistein is conditioned by BRCA1 mutations.
    Privat M; Aubel C; Arnould S; Communal Y; Ferrara M; Bignon YJ
    Biochem Biophys Res Commun; 2009 Feb; 379(3):785-9. PubMed ID: 19126406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions.
    Smith PD; Crossland S; Parker G; Osin P; Brooks L; Waller J; Philp E; Crompton MR; Gusterson BA; Allday MJ; Crook T
    Oncogene; 1999 Apr; 18(15):2451-9. PubMed ID: 10229196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
    Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
    Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of BRCA1 expression affects alcohol-induced transcription of RNA Pol III-dependent genes.
    Zhong Q; Shi G; Zhang Y; Lu L; Levy D; Zhong S
    Gene; 2015 Feb; 556(1):74-9. PubMed ID: 25447904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of serum from sepsis patients on epithelial cell migration in vitro: a case control study.
    Jaurila H; Koivukangas V; Koskela M; Gäddnäs F; Salo S; Korvala J; Risteli M; Karhu T; Herzig KH; Salo T; Ala-Kokko TI
    J Transl Med; 2017 Jan; 15(1):11. PubMed ID: 28086962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells.
    Fedier A; Steiner RA; Schwarz VA; Lenherr L; Haller U; Fink D
    Int J Oncol; 2003 May; 22(5):1169-73. PubMed ID: 12684687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation.
    Bai F; Smith MD; Chan HL; Pei XH
    Oncogene; 2013 May; 32(22):2715-25. PubMed ID: 22777348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
    Woo RA; Poon RY
    Genes Dev; 2004 Jun; 18(11):1317-30. PubMed ID: 15175263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.